Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05261009 · ClinicalTrials.gov registry record · Phase 4
PENG Block Versus LP Block for THA Postop Pain
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 154
- Enrollment target
NCT05261009 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 154 participants.
The verdict
NCT05261009, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 154 participants
- Enrollment target
Study Summary
The purpose of this randomized, double blinded, prospective study is to compare the postoperative analgesia provided by the PENG block to that provided by the LPB for patients undergoing primary anterior approach THA.
Interventions
- DRUG Peri-capsular Nerve Group (PENG)
- OTHER Lumbar Plexus Block (LPB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2022-06-13 |
| Est. Completion | 2023-07-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05261009
The ClinicalTrials.gov registry entry for NCT05261009 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peri-capsular Nerve Group (PENG) is the first listed.
NCT05261009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05261009 about?
NCT05261009 is a clinical study titled "PENG Block Versus LP Block for THA Postop Pain". The purpose of this randomized, double blinded, prospective study is to compare the postoperative analgesia provided by the PENG block to that provided by the LPB for patients undergoing primary anterior approach THA.
What is the current status of trial NCT05261009?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 154 participants. The study started on 2022-06-13. Estimated completion is 2023-07-20.
What interventions are being tested in trial NCT05261009?
The interventions under investigation include: Peri-capsular Nerve Group (PENG) (DRUG), Lumbar Plexus Block (LPB) (OTHER).
Who is sponsoring clinical trial NCT05261009?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.